Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions

JAMA Internal Medicine- United States

doi 10.1001/jamainternmed.2015.6102

Full Text

Abstract

Available in

Categories

Internal Medicine

Date

January 1, 2016

Authors

Ioannis Konstantinidis

Girish N. Nadkarni

Chirag R. Parikh

Publisher

American Medical Association (AMA)

Related search

Fibroblast Growth Factor 23 and Cardiovascular Disease in Patients With Chronic Kidney Disease

Renal Replacement Therapy

English

REPRINT Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular Disease

Internal Medicine

English

Cardiovascular Risks in Chronic Kidney Disease Pediatric Patients (Review)

Experimental and Therapeutic Medicine

Cancer Research

English

16. The Control of Cardiovascular Diseases of the Patients With Chronic Kidney Disease

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

English

Cinacalcet in Patients With Chronic Kidney Disease: A Cumulative Meta-Analysis of Randomized Controlled Trials

Molecular Biology

English

Managing Cardiovascular Risk in People With Chronic Kidney Disease: A Review of the Evidence From Randomized Controlled Trials

Therapeutic Advances in Chronic Disease

English

Economic Impact Associated With Pharmaceutical Interventions in Cardiovascular Disease

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

English

Novel Combined Management Approaches to Patients With Diabetes, Chronic Kidney Disease and Cardiovascular Disease

Journal of the Royal College of Physicians of Edinburgh, The

English

C-Reactive Protein as a Predictor of Cardiovascular Events in Elderly Patients With Chronic Kidney Disease

Journal of Nephrology

English